Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonresponsiveness to antianginal therapy--a frequent problem?

W Schulz1

  • 1Faculty of Internal Medicine, University Hospital, Frankfurt/Main, Federal Republic of Germany.

Cardiovascular Drugs and Therapy
|May 1, 1988
PubMed
Summary

Individualized antianginal therapy is crucial due to patient and drug variations impacting treatment outcomes. An empiric approach, prioritizing drugs with high response rates and minimal side effects, is recommended for managing angina.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glyphosate contamination in European rivers not from herbicide application?

Water research·2024
Same author

An ecotoxicological view on neurotoxicity assessment.

Environmental sciences Europe·2019
Same author

A novel network analysis tool to identify relationships between disease states and risks for red blood cell alloimmunization.

Vox sanguinis·2017
Same author

[Attitudes towards psychotherapy in South Korea and Germany : A cross-cultural comparative study].

Der Nervenarzt·2016
Same author

Physical Activity and Exercise Interventions in the Workplace Impacting Work Outcomes: A Stakeholder-Centered Best Evidence Synthesis of Systematic Reviews.

The international journal of occupational and environmental medicine·2016
Same author

Mental Health Interventions in the Workplace and Work Outcomes: A Best-Evidence Synthesis of Systematic Reviews.

The international journal of occupational and environmental medicine·2016

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Nonresponsiveness to antianginal treatment presents significant variability.
  • Patient pathophysiology and drug pharmacology are key factors influencing treatment outcomes.
  • Individualized therapy is desirable to optimize patient response.

Purpose of the Study:

  • To highlight the challenges in predicting antianginal treatment outcomes.
  • To emphasize the need for personalized antianginal drug selection.
  • To recommend a practical approach for daily clinical practice.

Main Methods:

  • The study discusses patient-specific factors like disease severity, vasospastic components, and organic vessel involvement.
  • It analyzes drug-specific properties including dose-finding, tolerance, spasmolytic activity, and side effects.

Related Experiment Videos

  • Predictive modeling based on diagnostic evaluations is considered but deemed impractical for routine use.

    • Main Results:

    • Treatment outcomes for angina are not fully predictable, even with comprehensive diagnostics.
    • The clinical relevance of vasospastic components in multivessel disease is difficult to ascertain.
    • Invasive evaluations for optimal drug selection are not feasible for all patients.

    Conclusions:

    • An empiric approach to antianginal drug selection is recommended for routine clinical practice.
    • Preference should be given to drugs demonstrating high response rates.
    • Minimizing potential adverse effects and concerns is a priority in drug selection.